1103
L&H
document
June 1, 2012 — 00:00

Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.

L&H
document
June 1, 2012 — 00:00

Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.

document
May 3, 2012 — 00:00

SCOR records net income of EUR 104 million in the 1st quarter 2012, confirming the dynamism of its franchise. SCOR Global Life Embedded Value grows by 50% to EUR 3.3 billion.

L&H
document
May 3, 2012 — 00:00

SCOR Global Life Embedded Value reaches EUR 3.3 billion in 2011 (EUR 18.0 per share), continuing to provide the SCOR group with significant earnings and strong capital repatriation.

L&H
document
April 30, 2012 — 00:00

The introduction of the new European supervisory System, Solvency II, is around the corner, even though now with a modified timetable compared to the initial planning.

L&H
document
April 30, 2012 — 00:00

The introduction of the new European supervisory System, Solvency II, is around the corner, even though now with a modified timetable compared to the initial planning.